Event JSON
{
"id": "c3089582375595486c3199345c58631141a884917c087d2d788fa4d15e67cc29",
"pubkey": "436e1e13476073838845600e053a28604c26f72b4f71a13338da0a5fd43aa946",
"created_at": 1717502520,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/@egghat/112558245207775306",
"web"
],
[
"t",
"goodnews"
],
[
"proxy",
"https://mastodon.social/users/egghat/statuses/112558245207775306",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://mastodon.social/users/egghat/statuses/112558245207775306",
"pink.momostr"
]
],
"content": "THE GUARDIAN: NHS patients in England to be offered trials for world-first cancer vaccine https://www.theguardian.com/science/article/2024/may/31/nhs-patients-in-england-to-be-offered-trials-for-world-first-cancer-vaccine\nDer Gag ist: der Impfstoff ist maßgeschneidert auf den Patienten. Hersteller ist Biontech, nach UK geht‘s, weil da mehr Daten vorliegen.\n#GoodNews",
"sig": "169738db26ea99991292e1b3901f0d9b5c6d47efbbdd1108f7d08b91ea2c953df4f92b9ac2449b31cbe11ce56d32161e92b9a188f11af324adea50f207ab9203"
}